Finance

Lists
Why is 600513 up 2.29%?
Dive Deeper
600513:SHA
Jiangsu Lianhuan Pharmaceutical Co. Ltd
CNÂ¥12.97
+2.29%
(+0.29) 1D
Nov 4, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600513...
Open
CNÂ¥12.74
High
CNÂ¥12.98
Low
CNÂ¥12.60
Mkt. cap
3.62B
Avg. vol.
11.46M
Volume
6.70M
Dividend
0.54%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jul 8, 2026
52-wk high
CNÂ¥32.27
52-wk low
CNÂ¥12.27
EPS
-CNÂ¥0.17
Shares outstanding
285.46M
No. of employees
2K
Open
CNÂ¥12.74
High
CNÂ¥12.98
Low
CNÂ¥12.60
Mkt. cap
3.62B
Avg. vol.
11.46M
Volume
6.70M
Dividend
0.54%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jul 8, 2026
52-wk high
CNÂ¥32.27
52-wk low
CNÂ¥12.27
EPS
-CNÂ¥0.17
Shares outstanding
285.46M
No. of employees
2K
News stories
From web sources and news partners
About Jiangsu Lianhuan Pharmaceutical Co. Ltd
CEO-
Employees2.13K
Founded1999
Headquarters-
SectorPharmaceutical industry
Industry-
Websitelhpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
629.40M
810.63M
760.19M
757.34M
Cost of goods sold
414.86M
595.63M
525.07M
540.43M
Cost of revenue
414.86M
595.63M
525.07M
540.43M
Research and development expenses
97.69M
28.66M
34.29M
34.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
167.70M
162.54M
173.32M
157.75M
Operating expense
283.39M
195.29M
214.47M
188.22M
Total operating expenses
698.25M
790.92M
739.54M
728.65M
Operating income
-68.85M
19.71M
20.65M
28.69M
Other non operating income
60.41M
-742.69K
1.60M
-34.29M
EBT including unusual items
-86.11M
10.60M
11.80M
7.99M
EBT excluding unusual items
-15.95M
10.61M
11.98M
13.02M
Income tax expense
-29.68M
3.24M
4.41M
3.53M
Effective tax rate
34.47%
30.55%
37.36%
44.18%
Other operating expenses
10.33M
2.59M
6.26M
-2.40M
Net income
-63.27M
6.42M
4.10M
4.14M
Net profit margin
-10.05%
0.79%
0.54%
0.55%
Earnings per share
-
-
-
-
Interest and investment income
630.30K
17.72K
393.42K
18.25M
Interest expense
-7.80M
-8.37M
-9.88M
-411.13K
Net interest expenses
-7.17M
-8.35M
-9.49M
17.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.70M
43.85M
49.42M
52.83M
Gain or loss from assets sale
77.54K
-
-15.00K
15.00K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps